Bottom line
How much do IBB and FBT overlap?
30% of their top holdings overlap by weight. 13 securities appear in both funds' top 25, making up 37.8% of IBB's assets and 40.6% of FBT's. They share a meaningful core but differ in the rest of the portfolio.
IBB holds far more positions (254 vs 32), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings IBB and FBT have in common
| Holding | % of IBB | % of FBT | Overlap |
|---|---|---|---|
| Vertex Pharmaceuticals, Inc. | 7.66% | 3.07% | 3.07% |
| Amgen, Inc. | 7.50% | 2.78% | 2.78% |
| Alnylam Pharmaceuticals, Inc. | 5.68% | 2.52% | 2.52% |
| Argenx SE | 3.15% | 3.13% | 3.13% |
| Natera, Inc. | 2.11% | 3.79% | 2.11% |
| Biogen, Inc. | 2.03% | 3.37% | 2.03% |
| United Therapeutics Corp. | 1.82% | 2.56% | 1.82% |
| Incyte Corp. | 1.62% | 3.18% | 1.62% |
| Illumina, Inc. | 1.41% | 3.92% | 1.41% |
| Genmab A/S | 1.38% | 2.62% | 1.38% |
| Neurocrine Biosciences, Inc. | 1.34% | 3.53% | 1.34% |
| Exelixis, Inc. | 1.07% | 3.32% | 1.07% |
| BioMarin Pharmaceutical, Inc. | 1.02% | 2.83% | 1.02% |
Source: SEC Form N-PORT (periods Sep 30, 2025 / Jun 30, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in IBB
- BlackRock Funds III — 13.18%
- Gilead Sciences, Inc. — 7.52%
- Regeneron Pharmaceuticals, Inc. — 5.70%
- IQVIA Holdings, Inc. — 3.18%
- Insmed, Inc. — 2.95%
- Mettler-Toledo International, Inc. — 2.49%
- BeOne Medicines Ltd. — 2.11%
- Waters Corp. — 1.77%
- Medpace Holdings, Inc. — 1.16%
- Ionis Pharmaceuticals, Inc. — 1.03%
- Madrigal Pharmaceuticals, Inc. — 0.92%
- Moderna, Inc. — 0.88%
Only in FBT
- Corcept Therapeutics Inc — 5.60%
- Neogenomics Inc — 5.12%
- Veracyte Inc — 5.10%
- Bruker Corp — 4.32%
- Alkermes Plc — 4.24%
- Krystal Biotech Inc — 3.87%
- Axsome Therapeutics Inc — 3.71%
- Bio-techne Corp — 3.43%
- Arrowhead Pharmaceuticals Inc — 3.38%
- Halozyme Therapeutics Inc — 3.11%
- Repligen Corp — 3.07%
- Biontech Se — 2.63%
Asset mix
| Asset type | IBB | FBT |
|---|---|---|
| Stocks | 99.8% | 100.0% |
| Cash & short-term funds | 13.4% | 0.1% |
Source: SEC Form N-PORT (periods Sep 30, 2025 / Jun 30, 2026)
Country mix
| Country | IBB | FBT |
|---|---|---|
| US | 98.6% | 85.0% |
| NL | 4.3% | 3.1% |
| IE | 0.5% | 4.2% |
| CH | 2.7% | 2.5% |
| DE | 0.7% | 2.6% |
| DK | 2.2% | 2.6% |
| GB | 1.0% | — |
| KY | 0.9% | — |
Source: SEC Form N-PORT (periods Sep 30, 2025 / Jun 30, 2026)
Check another pair
FAQ
How much do IBB and FBT overlap?
What stocks do IBB and FBT have in common?
Should I own both IBB and FBT?
Which holds more stocks, IBB or FBT?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.